Showing results (341-350 of 759) with videos related to

Sort By:
Pageof 76
The Lancet. Gastroenterology & Hepatology|May 10, 2025
Organ preservation after total neoadjuvant therapy for locally advanced rectal cancer (CAO/ARO/AIO-16): an open-label, multicentre, single-arm, phase 2 trialCihan Gani, Emmanouil Fokas, Bülent Polat, et al.
The Lancet. Gastroenterology & Hepatology|July 24, 2025
Anti-TL1A antibody, afimkibart, in moderately-to-severely active ulcerative colitis (TUSCANY-2): a multicentre, double-blind, treat-through, multi-dose, randomised, placebo-controlled, phase 2b trialSilvio Danese, Jessica R Allegretti, Stefan Schreiber, et al.
The Lancet. Gastroenterology & Hepatology|August 8, 2025
Recompensation in decompensated cirrhosisMadhumita Premkumar, Patrick S Kamath, Thomas Reiberger, et al.
The Lancet. Gastroenterology & Hepatology|July 27, 2025
Estimating the annual number of hepatitis C virus infections through vertical transmission at country, regional, and global levels: a data synthesis studyAdam Trickey, Adelina Artenie, Jordan J Feld, et al.
The Lancet. Gastroenterology & Hepatology|October 13, 2025
Fatigue in people with primary biliary cholangitis: a position paper from the European Reference Network for Rare Liver DiseasesOzgur M Koc, Anne-Kristin Toussaint, Aurelie Untas, et al.
The Lancet. Gastroenterology & Hepatology|October 8, 2025
Endoscopic versus surgical gastroenterostomy for palliation of malignant gastric outlet obstruction (ENDURO): a randomised controlled trialYorick L van de Pavert, Janine B Kastelijn, Marc G Besselink, et al.
The Lancet. Gastroenterology & Hepatology|February 16, 2026
Pharmacotherapy for metabolic dysfunction-associated steatohepatitis: heart-liver co-managementXiao-Dong Zhou, Jeffrey V Lazarus, Chayakrit Krittanawong, et al.
The Lancet. Gastroenterology & Hepatology|June 15, 2025
Primary biliary cholangitis and the narrowing gap towards optimal disease controlGuilherme Grossi Lopes Cançado, Ana Lleo, Cynthia Levy, et al.
The Lancet. Gastroenterology & Hepatology|March 16, 2025
Software-based versus visual assessment of the minimal ablative margin in patients with liver tumours undergoing percutaneous thermal ablation (COVER-ALL): a randomised phase 2 trialBruno C Odisio, Jessica Albuquerque, Yuan-Mao Lin, et al.
The Lancet. Gastroenterology & Hepatology|March 16, 2026
Efficacy of antiviral therapy in adults with chronic hepatitis B according to baseline hepatitis B virus DNA and alanine aminotransferase concentrations: a systematic review and meta-analysisYu Ri Im, Si Emma Chen, Rukmini Jagdish, et al.
Pageof 76